BioCentury
ARTICLE | Company News

Signum Dermalogix, Dermata Therapeutics deal

April 27, 2015 7:00 AM UTC

Signum granted Dermata exclusive, worldwide rights to SIG990. An IND for the rosacea candidate has been cleared by the FDA. Dermata is responsible for clinical development of the topical anti-inflamm...